US EditionRicardo Damas, New Vice President and General Director of Alexion (Astrazeneca) in Spain and Portugal
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Alexion, the rare diseases group of AstraZeneca, has appointed Ricardo Damas vice president and general director for Spain and Portugal, and will take over Leticia Beleta, reports the biopharmaceutical in a statement this Wednesday. With more than 25 years of international experience in the pharmaceutical industry, Damas also occupied positions of responsibility in [...] La entrada Ricardo Damas, new vice president and general director of Alexio…
Alexion, the rare diseases group of Astrazeneca, has announced the appointment of Ricardo Damas as new vice president & general manager (GM) for Spain and Portugal. During his term, Damas will strengthen Alexion’s leadership in the areas of rare hematology, nephrology, bone metabolism and neurology, as well as his expansion to new areas such as Endocrinology, Cardiology and rare tumors. He will do so by maintaining the focus on innovation, colla…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
